# Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis

> **NCT00518557** · NA · UNKNOWN · sponsor: **Southeast University, China** · enrollment: 60 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Transcatheter Arterial Chemoembolization

## Key facts

- **NCT ID:** NCT00518557
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518557, "Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00518557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*